Reactogenicity and Humoral Immune Response after Heterologous Vaxzevria/Comirnaty Vaccination in a Group of Individuals Vaccinated in the AOU Policlinic “G. Martino” (Messina, Italy): A Retrospective Cohort Study

Reactogenicity and Humoral Immune Response after Heterologous Vaxzevria/Comirnaty Vaccination in a Group of Individuals Vaccinated in the AOU Policlinic “G. Martino” (Messina, Italy): A Retrospective Cohort Study

On 11 June 2021, the Italian Ministry of Health authorized the heterologous vaccination schedule. The goals of our retrospective study were to (a) evaluate the undesirable effects after the administration of Vaxzevria and Comirnaty vaccines; (b) evaluate the antibody response after 28 days from the...

Full description

Bibliographic Details
Main Authors: Roberto Venuto, Ioselita Giunta, Mario Vaccaro, Vincenza La Fauci, Concetta Ceccio, Francesco Fedele, Antonino Privitera, Federica Denaro, Giuseppe Pantò, Rosaria Cortese, Giovanna Visalli, Smeralda D’Amato, Andrea Squeri, Raffaele Squeri, Cristina Genovese
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Vaccines
Subjects:
COVID-19
Comirnaty
Vaxzevria
heterologous vaccination regimen COVID-19
homologous vaccination regimen COVID-19
Online Access:https://www.mdpi.com/2076-393X/10/11/1803

Internet

https://www.mdpi.com/2076-393X/10/11/1803

Similar Items